Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Emily Smith is active.

Publication


Featured researches published by Emily Smith.


Nucleic Acids Research | 2010

Cell-type-specific long-range looping interactions identify distant regulatory elements of the CFTR gene

Nele Gheldof; Emily Smith; Tomoko M. Tabuchi; Christoph M. Koch; Ian Dunham; John A. Stamatoyannopoulos; Job Dekker

Identification of regulatory elements and their target genes is complicated by the fact that regulatory elements can act over large genomic distances. Identification of long-range acting elements is particularly important in the case of disease genes as mutations in these elements can result in human disease. It is becoming increasingly clear that long-range control of gene expression is facilitated by chromatin looping interactions. These interactions can be detected by chromosome conformation capture (3C). Here, we employed 3C as a discovery tool for identification of long-range regulatory elements that control the cystic fibrosis transmembrane conductance regulator gene, CFTR. We identified four elements in a 460-kb region around the locus that loop specifically to the CFTR promoter exclusively in CFTR expressing cells. The elements are located 20 and 80 kb upstream; and 109 and 203 kb downstream of the CFTR promoter. These elements contain DNase I hypersensitive sites and histone modification patterns characteristic of enhancers. The elements also interact with each other and the latter two activate the CFTR promoter synergistically in reporter assays. Our results reveal novel long-range acting elements that control expression of CFTR and suggest that 3C-based approaches can be used for discovery of novel regulatory elements.


Methods | 2012

Analysis of long-range chromatin interactions using Chromosome Conformation Capture

Natalia Naumova; Emily Smith; Ye Zhan; Job Dekker

Chromosome Conformation Capture, or 3C, is a pioneering method for investigating the three-dimensional structure of chromatin. 3C is used to analyze long-range looping interactions between any pair of selected genomic loci. Most 3C studies focus on defined genomic regions of interest that can be up to several hundred Kb in size. The method has become widely adopted and has been modified to increase throughput to allow unbiased genome-wide analysis. These large-scale adaptations are presented in other articles in this issue of Methods. Here we describe the 3C procedure in detail, including the appropriate use of the technology, the experimental set-up, an optimized protocol and troubleshooting guide, and considerations for data analysis. The protocol described here contains previously unpublished improvements, which save time and reduce labor. We pay special attention to primer design, appropriate controls and data analysis. We include notes and discussion based on our extensive experience to help researchers understand the principles of 3C-based techniques and to avoid common pitfalls and mistakes. This paper represents a complete resource and detailed guide for anyone who desires to perform 3C.


American Journal of Human Genetics | 2016

Invariant TAD Boundaries Constrain Cell-Type-Specific Looping Interactions between Promoters and Distal Elements around the CFTR Locus

Emily Smith; Bryan R. Lajoie; Gaurav Jain; Job Dekker

Three-dimensional genome structure plays an important role in gene regulation. Globally, chromosomes are organized into active and inactive compartments while, at the gene level, looping interactions connect promoters to regulatory elements. Topologically associating domains (TADs), typically several hundred kilobases in size, form an intermediate level of organization. Major questions include how TADs are formed and how they are related to looping interactions between genes and regulatory elements. Here we performed a focused 5C analysis of a 2.8 Mb chromosome 7 region surrounding CFTR in a panel of cell types. We find that the same TAD boundaries are present in all cell types, indicating that TADs represent a universal chromosome architecture. Furthermore, we find that these TAD boundaries are present irrespective of the expression and looping of genes located between them. In contrast, looping interactions between promoters and regulatory elements are cell-type specific and occur mostly within TADs. This is exemplified by the CFTR promoter that in different cell types interacts with distinct sets of distal cell-type-specific regulatory elements that are all located within the same TAD. Finally, we find that long-range associations between loci located in different TADs are also detected, but these display much lower interaction frequencies than looping interactions within TADs. Interestingly, interactions between TADs are also highly cell-type-specific and often involve loci clustered around TAD boundaries. These data point to key roles of invariant TAD boundaries in constraining as well as mediating cell-type-specific long-range interactions and gene regulation.


Human Mutation | 2013

Rare Nonconservative LRP6 Mutations Are Associated with Metabolic Syndrome

Rajvir Singh; Emily Smith; Mohsen Fathzadeh; Wenzhong Liu; Gwang-woong Go; Lakshman Subrahmanyan; Saeed Faramarzi; William J. McKenna; Arya Mani

A rare mutation in LRP6 has been shown to underlie autosomal dominant coronary artery disease (CAD) and metabolic syndrome in an Iranian kindred. The prevalence and spectrum of LRP6 mutations in the disease population of the United States is not known. Two hundred white Americans with early onset familial CAD and metabolic syndrome and 2,000 healthy Northern European controls were screened for nonconservative mutations in LRP6. Three novel mutations were identified, which cosegregated with the metabolic traits in the kindreds of the affected subjects and none in the controls. All three mutations reside in the second propeller domain, which plays a critical role in ligand binding. Two of the mutations substituted highly conserved arginines in the second YWTD domain and the third substituted a conserved glycosylation site. The functional characterization of one of the variants showed that it impairs Wnt signaling and acts as a loss of function mutation.


Circulation-cardiovascular Genetics | 2017

Application of Whole Exome Sequencing in the Clinical Diagnosis and Management of Inherited Cardiovascular Diseases in Adults.

Sara B. Seidelmann; Emily Smith; Lakshman Subrahmanyan; Daniel J. Dykas; Maen D. Abou Ziki; Bani Azari; Fady Hannah-Shmouni; Yuexin Jiang; Joseph G. Akar; Mark Marieb; Daniel Jacoby; Allen E. Bale; Richard P. Lifton; Arya Mani

Background— With the advent of high throughput sequencing, the identification of genetic causes of cardiovascular disease (CVD) has become an integral part of medical diagnosis and management and at the forefront of personalized medicine in this field. The use of whole exome sequencing for clinical diagnosis, risk stratification, and management of inherited CVD has not been previously evaluated. Methods and Results— We analyzed the results of whole exome sequencing in first 200 adult patients with inherited CVD, who underwent genetic testing at the Yale Program for Cardiovascular Genetics. Genetic diagnosis was reached and reported with a success rate of 26.5% (53 of 200 patients). This compares to 18% (36 of 200) that would have been diagnosed using commercially available genetic panels (P=0.04). Whole exome sequencing was particularly useful for clinical diagnosis in patients with aborted sudden cardiac death, in whom the primary insult for the presence of both depressed cardiac function and prolonged QT had remained unknown. The analysis of the remaining cases using genome annotation and disease segregation led to the discovery of novel candidate genes in another 14% of the cases. Conclusions— Whole exome sequencing is an exceptionally valuable screening tool for its capability to establish the clinical diagnosis of inherited CVDs, particularly for poorly defined cases of sudden cardiac death. By presenting novel candidate genes and their potential disease associations, we also provide evidence for the use of this genetic tool for the identification of novel CVD genes. Creation and sharing of exome databases across centers of care should facilitate the discovery of unknown CVD genes.


Cardiology in Review | 2016

A Case for Inclusion of Genetic Counselors in Cardiac Care.

Patricia Arscott; Colleen Caleshu; Katrina E. Kotzer; Sarah Kreykes; Teresa M. Kruisselbrink; Kate M. Orland; Christina Rigelsky; Emily Smith; Katherine Spoonamore; Joy Larsen Haidle; Monica Marvin; Michael J. Ackerman; Azam Hadi; Arya Mani; Steven R. Ommen; Sara Cherny

Recent advances in genetic testing for heritable cardiac diseases have led to an increasing involvement of the genetic counselor in cardiology practice. We present a series of cases collected from a nationwide query of genetics professionals regarding issues related to cost and utilization of genetic testing. Three themes emerged across cases: (1) choosing the most appropriate genetic test, (2) choosing the best person to test, and (3) interpreting results accurately. These cases demonstrate that involvement of a genetic counselor throughout the evaluation, diagnosis, and continuing management of individuals and families with inherited cardiovascular conditions helps to promote the efficient use of healthcare dollars.


Clinical Genetics | 2018

Deleterious protein‐altering mutations in the SCN10A voltage‐gated sodium channel gene are associated with prolonged QT

M.D. Abou Ziki; Sara B. Seidelmann; Emily Smith; Gourg Atteya; Yuexin Jiang; R.G. Fernandes; Mark Marieb; Joseph G. Akar; Arya Mani

Long QT syndrome (LQT) is a pro‐arrhythmogenic condition with life‐threatening complications. Fifteen genes have been associated with congenital LQT, however, the genetic causes remain unknown in more than 20% of cases.


Journal of Genetic Counseling | 2017

Erratum to: At the Heart of the Pregnancy: What Prenatal and Cardiovascular Genetic Counselors Need to Know about Maternal Heart Disease

Ana Morales; Dawn C. Allain; Patricia Arscott; Emily James; Gretchen MacCarrick; Brittney Murray; Crystal Tichnell; Amy R. Shikany; Sara Spencer; Sara M. Fitzgerald-Butt; Jessica D. Kushner; Christi Munn; Emily Smith; Katherine G. Spoonamore; Harikrishna Tandri; W. Aaron Kay

1 Department of Internal Medicine, The Ohio State University, Columbus, OH, USA 2 Human Genetics Division, The Ohio State University, 306 BRT, 460 W. 12th Ave, Columbus, OH 43210, USA 3 Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA 4 Allegheny General Hospital, Pittsburgh, PA, USA 5 Institute of Genetic Medicine, Johns Hopkins University, Baltimore, MD, USA 6 Division of Cardiology, Johns Hopkins University, Baltimore, MD, USA 7 Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA


Journal of the American College of Cardiology | 2016

CORONARY ARTERY DISSECTION IN EHLERS DANLOS SYNDROME

Emily Smith; Arya Mani

Coronary artery dissection is a rare complication of pregnancy. The underlying causes of the disorder remain vastly unknown. An association with collagen vascular disease has been described. A 42 year old woman presented to the emergency department with resting angina two weeks post delivery via


American Journal of Human Genetics | 2016

Erratum: Mutations in the Histone Modifier PRDM6 Are Associated with Isolated Nonsyndromic Patent Ductus Arteriosus (American Journal of Human Genetics (2016) 98(6) (1082–1091) (S000292971630057X) (10.1016/j.ajhg.2016.03.022))

Na Li; Lakshman Subrahmanyan; Emily Smith; Xiaoqing Yu; Samir Zaidi; Murim Choi; Shrikant Mane; Carol Nelson-Williams; Mohaddeseh Behjati; Mohammad Hossein Kazemi; Mohammad Hashemi; Mohsen Fathzadeh; Anand Narayanan; Likun Tian; Farhad Montazeri; Mitra Mani; Michael L. Begleiter; Brian G. Coon; Henry T. Lynch; Eric N. Olson; Hongyu Zhao; Jürgen Ruland; Richard P. Lifton; Arya Mani

‘‘Dorothy unstintingly gave her time and energy to assist others. She volunteered for numerous activities to benefit the clinical genetics community. She was a founding fellow of the American College of Medical Genetics and also a member of the founding board of directors of the American Board of Medical Genetics, for which she served as treasurer and helped to make up queries for the first group of examinees for the board. Along with the other examiners, she had to take the next examination to become board certified and a fellow herself, a requirement she took with good humor.’’

Collaboration


Dive into the Emily Smith's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sara B. Seidelmann

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Job Dekker

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge